Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Athenex, Avacta, Avenue, Bharat, Biontech, BMS, Celularity, Eisai, Gilead, Henlius, Iaso, Immunome, Merck & Co., Nabriva, Novo, Ocugen, On Target, Pfizer, Regentree, Selecta, Sigilon, Tracon, Unicycive, Variant, Verrica, Viracta.